ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
valueadd
|
206 |
52K |
5 |
12:19 |
12:19 |
ASX - By Stock
|
206
|
52K
|
5
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS Awarded $466,840 Contract from Penten
|
|
valueadd
|
9 |
1.7K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
9
|
1.7K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
20K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
107
|
20K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
20K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
107
|
20K
|
0
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
20K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
107
|
20K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
valueadd
|
22K |
11M |
32 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
22K
|
11M
|
32
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
valueadd
|
22K |
11M |
10 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
22K
|
11M
|
10
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
20K |
2 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
107
|
20K
|
2
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
20K |
5 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
107
|
20K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
valueadd
|
216 |
92K |
24 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
216
|
92K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
valueadd
|
303 |
118K |
6 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
303
|
118K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
valueadd
|
163 |
60K |
15 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
163
|
60K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
valueadd
|
163 |
60K |
12 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
163
|
60K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
valueadd
|
163 |
60K |
28 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
163
|
60K
|
28
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
valueadd
|
163 |
60K |
9 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
163
|
60K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
valueadd
|
163 |
60K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
163
|
60K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Presentation!
|
|
valueadd
|
106 |
33K |
8 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
106
|
33K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Presentation!
|
|
valueadd
|
106 |
33K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
106
|
33K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
valueadd
|
422 |
145K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
422
|
145K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is NOT a MULTI Bagger is a BAGGIES company
|
|
valueadd
|
85 |
27K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
85
|
27K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is NOT a MULTI Bagger is a BAGGIES company
|
|
valueadd
|
85 |
27K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
85
|
27K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Presentation!
|
|
valueadd
|
106 |
33K |
11 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
106
|
33K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Presentation!
|
|
valueadd
|
106 |
33K |
3 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
106
|
33K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is NOT a MULTI Bagger is a BAGGIES company
|
|
valueadd
|
85 |
27K |
3 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
85
|
27K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is NOT a MULTI Bagger is a BAGGIES company
|
|
valueadd
|
85 |
27K |
15 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
85
|
27K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is NOT a MULTI Bagger is a BAGGIES company
|
|
valueadd
|
85 |
27K |
35 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
85
|
27K
|
35
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
valueadd
|
303 |
118K |
17 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
118K
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
valueadd
|
303 |
118K |
49 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
118K
|
49
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.2M |
16 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
13K
|
6.2M
|
16
|
|
ASX - By Stock
|
PIL |
Re:
Daily Price Movement / General Discussion
|
|
valueadd
|
2.8K |
828K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
2.8K
|
828K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Oncolytic Virotherapy CF33 Patent Granted in China
|
|
valueadd
|
118 |
55K |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
118
|
55K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
valueadd
|
216 |
92K |
9 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
216
|
92K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.2M |
12 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
13K
|
6.2M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.2M |
2 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
13K
|
6.2M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.2M |
17 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
13K
|
6.2M
|
17
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
20K |
3 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
107
|
20K
|
3
|
|
ASX - By Stock
|
PIL |
Re:
Daily Price Movement / General Discussion
|
|
valueadd
|
2.8K |
828K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
2.8K
|
828K
|
1
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
34K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
169
|
34K
|
0
|
|
ASX - By Stock
|
PIL |
Re:
Daily Price Movement / General Discussion
|
|
valueadd
|
2.8K |
828K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
2.8K
|
828K
|
3
|
|
ASX - By Stock
|
PIL |
Re:
Daily Price Movement / General Discussion
|
|
valueadd
|
2.8K |
828K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
2.8K
|
828K
|
3
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
34K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
169
|
34K
|
0
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
34K |
0 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
169
|
34K
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
valueadd
|
31K |
15M |
12 |
22/03/24 |
22/03/24 |
Charts
|
31K
|
15M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.2M |
13 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
13K
|
6.2M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update
|
|
valueadd
|
30 |
18K |
46 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
30
|
18K
|
46
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
34K |
0 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
169
|
34K
|
0
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
34K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
169
|
34K
|
1
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
34K |
2 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
169
|
34K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.2M |
7 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
13K
|
6.2M
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Half Yearly Report and Accounts
|
|
valueadd
|
17 |
4.6K |
2 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
17
|
4.6K
|
2
|
|